| Literature DB >> 34940652 |
Bruno Reis1,2,3,4, Ana Teresa Gonçalves1,5, Paulo Santos2,3, Manuel Sardinha1, Luís E C Conceição1, Renata Serradeiro6, Jaume Pérez-Sánchez7, Josep Calduch-Giner7, Ulrike Schmid-Staiger8, Konstantin Frick9, Jorge Dias1, Benjamín Costas2,3.
Abstract
This work aimed to evaluate the effects of dietary supplementation with β-glucans extracted from yeast (Saccharomyces cerevisiae) and microalga (Phaeodactylum tricornutum) on gene expression, oxidative stress biomarkers and plasma immune parameters in gilthead seabream (Sparus aurata) juveniles. A practical commercial diet was used as the control (CTRL), and three others based on CTRL were further supplemented with different β-glucan extracts. One was derived from S. cerevisiae (diet MG) and two different extracts of 21% and 37% P. tricornutum-derived β-glucans (defined as Phaeo21 and Phaeo37), to give a final 0.06% β-glucan dietary concentration. Quadruplicate groups of 95 gilthead seabream (initial body weight: 4.1 ± 0.1 g) were fed to satiation three times a day for 8 weeks in a pulse-feeding regimen, with experimental diets intercalated with the CTRL dietary treatment every 2 weeks. After 8 weeks of feeding, all groups showed equal growth performance and no changes were found in plasma innate immune status. Nonetheless, fish groups fed β-glucans supplemented diets showed an improved anti-oxidant status compared to those fed CTRL at both sampling points (i.e., 2 and 8 weeks). The intestinal gene expression analysis highlighted the immunomodulatory role of Phaeo37 diet after 8 weeks, inducing an immune tolerance effect in gilthead seabream intestine, and a general down-regulation of immune-related gene expression. In conclusion, the results suggest that the dietary pulse administration of a P. tricornutum 37% enriched-β-glucans extract might be used as a counter-measure in a context of gut inflammation, due to its immune-tolerant and anti-oxidative effects.Entities:
Keywords: Phaeodactylum tricornutum; Saccharomyces cerevisiae; Sparus aurata; immune tolerance; pulse feeding; β-glucans
Mesh:
Substances:
Year: 2021 PMID: 34940652 PMCID: PMC8704051 DOI: 10.3390/md19120653
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Growth performance parameters in gilthead seabream juveniles after 8 weeks of feeding regimen. Data are the mean ± SEM (n = 4).
| 8 Weeks | ||||
|---|---|---|---|---|
| DIETS | CTRL | MG | Phaeo21 | Phaeo37 |
| IBW | 4.18 ± 0.04 | 4.12 ± 0.02 | 4.12 ± 0.05 | 4.15 ± 0.05 |
| FBW | 41.36 ± 0.81 | 42.48 ± 0.43 | 42.08 ± 0.53 | 41.93 ± 0.97 |
| RGR | 3.77 ± 0.03 | 3.83 ± 0.02 | 3.82 ± 0.03 | 3.8 ± 0.03 |
| FCR | 1.20 ± 0.01 | 1.19 ± 0.01 | 1.21 ± 0.02 | 1.19 ± 0.04 |
IBW: initial body weight (g); FBW: final body weight (g); RGR: relative growth rate (% average body weight/day) and FCR: feed conversion ratio.
Percentage values of peripheral blood leucocytes (thrombocytes, lymphocytes, monocytes and neutrophils) in gilthead seabream juveniles after 2 and 8 weeks of feeding regimen. Data are the mean ± SEM (n = 12).
| 2 Weeks | 8 Weeks | |||||||
|---|---|---|---|---|---|---|---|---|
| DIETS | CTRL | MG | Phaeo21 | Phaeo37 | CTRL | MG | Phaeo21 | Phaeo37 |
| CELLS (%) | ||||||||
| Thrombocytes | 65.2 ± 2.0 | 63.0 ± 2.2 | 60.3 ± 1.8 | 64.7 ± 1.6 | 71.2 b ± 2.6 | 78.5 a ± 1.4 | 76.4 a,b ± 2.5 | 81.0 a ± 0.8 |
| Lymphocytes | 24.1 b ± 1.5 | 28.3 a,b ± 1.9 | 30.7 a ± 1.4 | 24.8 b ± 1.3 | 18.4 a ± 2.5 | 13.0 b ± 1.0 | 13.1 b ± 2.6 | 13.4 a,b ± 0.8 |
| Monocytes | 5.3 ± 0.8 | 3.5 ± 0.7 | 4.4 ± 0.7 | 5.2 ± 0.4 | 3.4 ± 0.6 | 2.4 ± 0.7 | 3.1 ± 0.6 | 2.0 ± 0.5 |
| Neutrophils | 4.4 ± 1.0 | 4.1 ± 0.9 | 4.1 ± 0.7 | 4.8 ± 0.7 | 4.7 ± 0.4 | 5.6 ± 0.6 | 4.3 ± 0.7 | 3.6 ± 0.6 |
Different superscript letters indicate significant differences between diets (p < 0.05) within the same sampling point.
Plasma immune parameters of gilthead seabream juveniles after 2 and 8 weeks feeding (antiprotease activity, bactericidal activity and immunoglobulin M). Data are the mean ± SEM (n = 12). Different letters indicate significant differences between dietary treatments (p < 0.05).
| 2 Weeks | 8 Weeks | |||||||
|---|---|---|---|---|---|---|---|---|
| DIETS | CTRL | MG | Phaeo21 | Phaeo37 | CTRL | MG | Phaeo21 | Phaeo37 |
| Antiprotease act (%) | 95.7 ± 0.6 | 96.0 ± 0.5 | 95.5 ± 0.7 | 95.4 ± 0.6 | 97.9 ± 0.2 | 98.1 ± 0.1 | 97.9 ± 0.2 | 98.2 ± 0.2 |
| Bactericidal act (%) | 45.0 ± 6.3 | 35.5 ± 4.0 | 40.3 ± 6.6 | 45.4 ± 4.4 | 53.3 ± 7.2 | 56.5 ± 5.8 | 57.4 ± 6.8 | 61.8 ± 4.8 |
| IgM (OD 450 nm) | 0.31 ± 0.03 | 0.32 ± 0.03 | 0.37 ± 0.05 | 0.29 ± 0.03 | 0.62 ± 0.05 | 0.53 ± 0.03 | 0.47 ± 0.05 | 0.55 ± 0.03 |
Figure 1Liver oxidative stress biomarkers of gilthead seabream juveniles after 2 and 8 weeks feeding. Lipid peroxidation (LPO) (A); Catalase activity (CAT) (B); Superoxide dismutase activity (SOD) (C) and Total Glutathione (D). Data are the mean ± SEM (n = 12). Different lowercase letters indicate significant differences between dietary treatments (p < 0.05).
Figure 2Discriminant analysis of experimental groups based on all physiological biomarkers analysed in the target tissues (yellow marker indicates the centroids of each group) and variables loads for DF1 and DF2 at 2 and 8 weeks. (A) 2 weeks; (B) 8 weeks.
Figure 3Relative mRNA expression of pcna (A), cx32.2 (B), il10 (C) and fcl (D) genes in the anterior intestinal tissue of gilthead seabream juveniles fed the experimental diets for 2 and 8 weeks. Data are the mean ± SEM (n = 9). All data values for each gene were in reference to the expression level of cldn12 of CTRL fish with an arbitrary assigned value of 1. p values result from one-way ANOVA. Different lowercase letters indicate significant differences among dietary treatments (p < 0.05).
Figure 4Heat map showing the normalized mRNA levels of selected genes in the anterior intestinal tissue of gilthead seabream juveniles after 8 weeks of feeding. Each block represents the mean mRNA level quantified by qPCR (n = 9).
Figure 5(A) Partial least square discriminant analysis (PLS-DA) score plots of all gene expression biomarkers analysed in the proximal intestine of gilthead seabream juveniles along the two main components at 8 weeks. (B) Ordered list of markers by variable importance (VIP) in projection of PLS-DA model for group differentiation, as well as the fold-change (FC) in comparison to CTRL. Markers with VIP values > 1 after the first and second main components are represented.
Ingredients and proximate composition of experimental diets.
| Ingredients % | CTRL | MG | Phaeo21 | Phaeo37 |
|---|---|---|---|---|
| Fishmeal 1 | 20.00 | 20.00 | 20.00 | 20.00 |
| Fish protein hydrolysate 2 | 8.00 | 8.00 | 8.00 | 8.00 |
| Squid meal 3 | 21.00 | 21.00 | 21.00 | 21.00 |
| Krill meal 4 | 16.50 | 16.50 | 16.50 | 16.50 |
| Wheat gluten 5 | 11.50 | 11.50 | 11.50 | 11.50 |
| Wheat meal 6 | 0.29 | 0.19 | 0.13 | |
| Vitamin and mineral premix 7 | 2.00 | 2.00 | 2.00 | 2.00 |
| Lecithin 8 | 4.30 | 4.30 | 4.30 | 4.30 |
| Fish oil 9 | 6.50 | 6.50 | 6.50 | 6.50 |
| Binders, antioxidant and other additives 10 | 9.91 | 9.91 | 9.91 | 9.91 |
| Yeast beta-glucans 11 | 0.10 | |||
| Algae beta-glucans Phaeo21 12 | 0.29 | |||
| Algae beta-glucans Phaeo37 13 | 0.16 | |||
| Proximate composition | ||||
| Dry matter (DM) % | 94.60 | 94.20 | 94.20 | 94.50 |
| Ash, % DM | 9.60 | 9.50 | 9.50 | 9.50 |
| Crude protein, % DM | 62.90 | 62.80 | 62.80 | 62.90 |
| Crude fat, % DM | 17.10 | 17.10 | 17.10 | 17.10 |
| Gross energy (kJ g−1 DM) | 22.90 | 22.90 | 22.90 | 22.90 |
1 Super Prime: 66.3% CP, 11.5% CF, Pesquera Diamante, Peru; 2 CPSP 90: 82% CP 9% CF, Sopropêche, France; 3 Squid meal without guts: 83% CP, 4% CF, Sopropêche, France; 4 Krill meal: 61.1% CP, 17.4% CF, Aker Biomarine, Norway; 5 VITEN: 82% CP, 2.1% CF, Roquette, France; 6 Wheat meal: 10.2% CP; 1.2% CF, MOLISUR, Spain; 7 PREMIX Lda, Portugal: Vitamins (IU or mg/kg diet): DL-alpha tocopherol acetate, 200 mg; sodium menadione bisulphate, 50 mg; retinyl acetate, 40,000 IU; DL-cholecalciferol, 4000 IU; thiamin, 60 mg; riboflavin, 60 mg; pyridoxine, 40 mg; cyanocobalamin, 0.2 mg; nicotinic acid, 400 mg; folic acid, 30 mg; ascorbic acid, 1000 mg; inositol, 1000 mg; biotin, 6 mg; calcium panthotenate, 200 mg; choline chloride, 2000 mg, betaine, 1000 mg. Minerals (g or mg/kg diet): copper sulphate, 18 mg; ferric sulphate, 12 mg; potassium iodide, 1 mg; manganese oxide, 20 mg; sodium selenite, 0.02 mg; zinc sulphate, 27.5 mg; sodium chloride, 800 mg; excipient wheat middling’s; 8 LECICO GmbH, Germany; 9 Sopropêche, France; 10 Confidential blend of constant binders and other additives; 11 Macrogard, 67.2% beta-glucans, Biorigin, Brazil; 12 Beta-glucan rich biomass of microalgae (Phaeodactylum tricornutum from SAG culture collection) with 21% beta-glucans; 13 Beta-glucan rich extract of microalgae (Phaeodactylum tricornutum from SAG culture collection) with 37% beta-glucans.
Figure 6Schematic overview of the experimental design.
PCR-array layout for gene expression profiling of anterior intestine in seabream.
| Function | Gene | Symbol | GenBank |
|---|---|---|---|
| Epithelia integrity | proliferating cell nuclear antigen |
| KF857335 |
| transcription factor HES-1-B |
| KF857344 | |
| krueppel-like factor 4 |
| KF857346 | |
| claudin-12 |
| KF861992 | |
| claudin-15 |
| KF861993 | |
| cadherin-1 |
| KF861995 | |
| cadherin-17 |
| KF861996 | |
| tight junction protein ZO-1 |
| KF861994 | |
| desmoplakin |
| KF861999 | |
| gap junction Cx32.2 protein |
| KF862000 | |
| coxsackievirus and adenovirus receptor homolog |
| KF861998 | |
| Nutrient transport | intestinal-type alkaline phosphatase |
| KF857309 |
| liver type fatty acid-binding protein |
| KF857311 | |
| intestinal fatty acid-binding protein |
| KF857310 | |
| ileal fatty acid-binding protein |
| KF857312 | |
| Mucus production | mucin 2 |
| JQ277710 |
| mucin 13 |
| JQ277713 | |
| Interleukins | tumor necrosis factor-alpha |
| AJ413189 |
| interleukin 1 beta |
| AJ419178 | |
| interleukin 6 |
| EU244588 | |
| interleukin 7 |
| JX976618 | |
| interleukin 8 |
| JX976619 | |
| interleukin 10 |
| JX976621 | |
| interleukin 12 subunit beta |
| JX976624 | |
| interleukin 15 |
| JX976625 | |
| interleukin 34 |
| JX976629 | |
| Cell markers | cluster differentiation 4 |
| AM489485 |
| cluster differentiation 8 beta |
| KX231275 | |
| C-C chemokine receptor 3 |
| KF857317 | |
| C-C chemokine receptor 9 |
| KF857318 | |
| C-C chemokine receptor 11 |
| KF857319 | |
| C-C chemokine ck8/C-C motif chemokine ligand 20 |
| GU181393 | |
| macrophage colony-stimulating factor 1 receptor |
| AM050293 | |
| Ig production | immunoglobulin M |
| JQ811851 |
| immunoglobulin T membrane-bound form |
| KX599201 | |
| Pathogen associated | galectin 1 |
| KF862003 |
| microbial pattern | galectin 8 |
| KF862004 |
| (PAMP) | toll like receptor 2 |
| KF857323 |
| toll like receptor 5 |
| KF857324 | |
| toll like receptor 9 |
| AY751797 | |
| CD209 antigen-like protein D |
| KF857327 | |
| CD302 antigen |
| KF857328 | |
| macrophage mannose receptor 1 |
| KF857326 | |
| fucolectin |
| KF857331 |